The box promises to fight acne. It does not mention that, left in a hot car, it can also make a small amount of benzene, a known human carcinogen. That is not a contaminant sneaking in from a supplier. It is the active ingredient itself coming apart.
Benzoyl peroxide, or BPO, has treated acne for decades because it kills the bacteria involved and does it several ways at once. The catch, flagged by the New Haven lab Valisure in a March 2024 citizen petition to the FDA, backed by a peer-reviewed study, is that BPO is chemically unstable. Heat it and give it time, and some of it degrades into benzene. This is the part worth understanding. The earlier benzene scares in spray sunscreens and hand sanitizers came from dirty raw materials. Here the molecule you are paying for is the source.
What followed was two labs painting very different pictures. Valisure found benzene detectable in 94 of 99 BPO products straight off the shelf, mostly at low levels. Push them, and the numbers jump. In Valisure's 18-day stability test at 50 degrees Celsius, two products exceeded 1,500 parts per million; by the lab's account, a single Proactiv product held at 70 degrees, roughly a hot car, gave off airborne benzene at about 1,270 times the EPA's cancer-risk threshold for long-term inhalation, modeled as the tube outgassing inside a compact car.
Then the FDA ran its own numbers, and they were far calmer. In March 2025 the agency tested 95 BPO acne products; more than 90 percent had undetectable or extremely low benzene. Six were recalled at the US retail level: La Roche-Posay Effaclar Duo, two Proactiv items (the Emergency Blemish Relief Cream and the Skin Smoothing Exfoliator), two Walgreens store products, and an SLMD lotion, plus a Zapzyt gel pulled on its own track. These were US recalls under the FDA; the European-market versions of these products, La Roche-Posay's Effaclar Duo among them, were not part of the action. The FDA also took a swing at Valisure, cautioning that unvalidated third-party testing methods can report far higher benzene levels than are actually present in the products. Its own line: even decades of daily use pose a very low cancer risk.
So which is real? Both, measuring different things. The benchmark is 2 parts per million, the ceiling the FDA borrows from the international residual-solvent guideline that lists benzene as a solvent to avoid. Valisure's big exceedances came out of the heat oven, not the shelf, and the FDA's shelf testing found a narrow problem. The honest read is that heat and age are the variables. Christopher Bunick, the Yale dermatologist who co-authored the Valisure studies as an unpaid independent consultant, has been the loudest voice for caution, which is worth weighing against the FDA's shrug.
The regulatory fix is slow. Even before the acne story, the FDA in December 2023 told manufacturers to reformulate products thickened with carbomers made using benzene, a separate benzene source left over from how those gels are manufactured. None of that helps the tube already in your cabinet.
What helps the tube in your cabinet is storage and a calendar. Benzene formation is driven by heat and time, so the advice is boring and it works. Keep BPO products cool, out of the shower, off the radiator, and out of the glovebox in July. Use them before the expiration date and throw them out after. If a product is on the recall list, check the lot number against the FDA notice and return it. That is the whole intervention.
I am not going to tell you your acne cream is poisoning you, because the FDA's own testing says otherwise, and I have spent years watching this industry frighten people out of things that help them. Benzoyl peroxide still works. As the University of Calgary dermatologist Fatemah Jafarian told Yale Medicine, "Don't panic. Benzoyl peroxide in most cases can still be used safely with proper precautions." The useful takeaway is not a boycott. It is that an unstable molecule wants cool, dark, and fresh, and you can give it all three for free.
